Dib, A.
Polo, G.
Danaila, T.
Laurencin, C.
Prange, S.
Thobois, S. https://orcid.org/0000-0002-9639-6702
Article History
Received: 27 April 2024
Revised: 24 May 2024
Accepted: 26 May 2024
First Online: 3 June 2024
Declarations
:
: None for the present work. Outside the present work: ST has received personal fees and honorarium for conferences or consulting from Abbvie, Medtronic, Boston, Merz, Aguettant, NHC and travel and meeting grants from abbvie, Orkyn and the MDS. AD, GP, SP have nothing to declare. CL received personal honorarium from Everpharma and support for attending meeting from Abbvie. TD has received personal fees and honorarium for conferences or consulting from Abbvie, Medtronic, Boston, Elivie and meeting grants from Abbvie.
: The patient gave her informed consent for this publication. The manuscript has received an authorization by the local advisory board (number 24–5180).